|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.246 HKD | +0.41% |
|
-7.17% | +12.84% |
Tianda Pharmaceuticals Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 532.09 million. Net loss was HKD 24.16 million.
Basic loss per share from continuing operations was HKD 0.0112. Diluted loss per share from continuing operations was HKD 0.0112.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.84% | 67.43M | |
| +29.98% | 682B | |
| +32.39% | 586B | |
| -3.52% | 364B | |
| +18.59% | 327B | |
| +4.07% | 285B | |
| +16.50% | 240B | |
| +9.56% | 209B | |
| -9.04% | 203B | |
| +7.09% | 165B |
TIANDA PHARMACEUTICALS LIMITED 
